NIH-sponsored clinical trial of chikungunya vaccine opens
An experimental vaccine to protect against the mosquito-borne illness chikungunya is being tested in a Phase 2 trial sponsored by the NIH. Results from an initial trial were reported in 2014. The new trial is designed to enroll 400 healthy adult volunteers at six sites in the Caribbean. November 24, 2015